Gabriel Burchett

Gabriel Burchett is a skilled scientist with a focus on T Cell therapy development at 2seventy bio, where the role as Senior Associate Scientist I involves addressing tumor control and elimination challenges. Prior experience includes positions at bluebird bio as an Associate Scientist and at Lyra Therapeutics as a Process Development Engineer, where efforts centered on scale-up processes for Stage III clinical trials and the improvement of drug coating capabilities. Earlier roles also include work at SQZ Biotechnologies, developing cryopreservation techniques for preclinical pipelines, and at Emulate, Inc., where Gabriel contributed to the development of a Liver Chip platform for alcohol toxicity modeling. Educational background includes a Bachelor’s degree in Chemical Engineering and Biochemistry from Northeastern University.